Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axicabtagene ciloleucel in relapsed/refractory indolent non-Hodgkin lymphoma
NCT03105336Phase 2Completed
- Sponsor
- Kite Pharma
- Start
- Jun 2017
- Primary completion
- Dec 2024
- Modality
- CAR-T Cells
- Countries
- 2
01
Overview
A Phase 2 trial of axicabtagene ciloleucel in follicular lymphoma (FL), marginal zone lymphoma (MZL), sponsored by Kite Pharma. Started Jun 2017; status: completed.
02
Drugs
axicabtagene ciloleucel
03
Conditions
follicular lymphoma (FL)marginal zone lymphoma (MZL)
Beyond the preview
Go deeper on NCT03105336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03105336.